Epidemiology and clinical classification of onychomycosis.
about
Epidemiology of onychomycosis in Italy: prevalence data and risk factor identification.Use of diagnostic tests by dermatologists, podiatrists and family practitioners in the United States: pilot data from a cross-sectional survey.Psychosocial perception of adults with onychomycosis: a blinded, controlled comparison of 1,017 adult Hong Kong residents with or without onychomycosisA Case of Onychomycosis Caused by Rhodotorula glutinis.Onychomycosis: modern diagnostic and treatment approaches.Do fungi play a role in psoriatic nails?The cutaneous bacterium Janthinobacterium lividum inhibits the growth of Trichophyton rubrum in vitro.Mycology - an update Part 3: Dermatomycoses: topical and systemic therapy.Descriptive study of onychomycosis in a hospital in São PauloThe Efficacy and Prognostic Factors for Long Pulse Neodymium: Yttrium-Aluminum-Garnet Laser Treatment on Onychomycosis: A Pilot StudyReappraisal of Conventional Diagnosis for Dermatophytes.MALDI-TOF-Based Dermatophyte Identification.Tavaborole (AN-2690) for the treatment of onychomycosis of the toenail in adults.The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations.Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.Development of a novel polymerase chain reaction-enzyme-linked immunosorbent assay for the diagnosis of Trichophyton rubrum onychomycosis.Prevalence, Etiology, and Risk Factors of Tinea Pedis and Tinea Unguium in TunisiaAmorolfine 5% Nail Lacquer Exhibits Potent Antifungal Activity Compared to Three Acid-Based Devices Indicated for the Treatment of Onychomycosis: An In Vitro Nail Penetration AssayEpidemiology of onychomycosis in Serbia: a laboratory-based survey and risk factor identification.Nail clipping in onychomycosis.Epidemiology of onychomycosis in Crete, Greece: a 12-year study.Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays.Multicenter evaluation of a commercial PCR-enzyme-linked immunosorbent assay diagnostic kit (Onychodiag) for diagnosis of dermatophytic onychomycosis.Evaluation of the morphological effects of TDT 067 (terbinafine in Transfersome) and conventional terbinafine on dermatophyte hyphae in vitro and in vivo.Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study.Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.Antifungal activity of propolis extract against yeasts isolated from onychomycosis lesions.Efficacy of antifungal PACT in anin vitromodel of onychomycosis[Fungal nail infections - an update. Part 2 - From the causative agent to diagnosis - conventional and molecular procedures].A comprehensive study to evaluate the effect of constant low voltage iontophoresis on transungual deliveryCase Study of Onychomycosis Patients Treated with 1,064-nm Nd:YAG LaserToenail Onychomycosis in a Portuguese Geriatric Population
P2860
Q30998296-B0C5F2E0-A8A6-4AE4-AFFD-FA6B60E671D2Q33303044-4768F0D5-C7C3-49FF-9FD5-6245810BEF2CQ33936313-F73F5752-EB7E-4D31-B167-BC3BC7D3E426Q34310909-2E822335-CB55-40FA-85B5-FF7A5423B71CQ34440038-94A2C475-C7EC-45F0-A12C-B61B8F7F18F3Q34703147-7B381D3E-C337-47D0-BA6B-860E172EF9B0Q34966635-5C145073-D8EF-4232-A666-2609015137E2Q35616204-C47D4612-A7D7-4920-999C-1ED5AE433902Q35866516-E664BA85-3F57-4AF7-93E3-BA8C8CCAD27AQ36044473-3F5019FE-35DF-4221-A921-2720376AB79FQ36158255-7ED2D307-5226-4E91-B03A-8228EE06507CQ36162078-239B6C62-49E7-43C8-AE1E-A5EB33888A07Q38217420-6776F413-E6B3-45F6-9BEF-A646CAAF277FQ38270111-97F661DE-0A88-47E7-8DE9-B16FC6D4D4BDQ38395475-74F668E4-D7C1-40D2-B6A1-C412E7DB6831Q38398566-771C9B8A-89C3-41F0-A246-4C8F2A378A69Q38602870-AFFBF7E3-C12A-4F5D-8E95-E5BD57215AFDQ39190473-29349BE8-E43C-4B25-930B-9CE5D84FF0A4Q39548613-DDDB6ECA-25BB-4931-AE73-2EF94FEA3EEFQ40458567-5F7D47E6-4238-4708-95C5-A8F2085638B2Q40608450-8CBA7567-2E1F-4173-9B1E-D8DDFB4653E4Q40795233-F0DE5F9D-E017-4F7B-A049-ECB28A47A58AQ41826970-51CC8ADF-4064-4484-840C-BB6F876BEEFBQ42110698-51A2A838-43E0-44C4-B8A1-3936152C00F6Q43534478-8C500D5B-EB2C-4456-95B5-BB8186DD21E2Q45366391-5D0520CE-6AB1-4752-A73B-37DC13FC01C2Q48325899-A1C04306-8E0D-4C58-8CBA-F98794B47E61Q52673783-E8645225-3228-4F39-AC4D-4D33930FE8EAQ53747721-94F53A28-DFFA-409D-9116-C9DB59E889C4Q54341845-F4CAC07C-A55D-4DED-B31F-C0FA191758C5Q56035511-77D0D5A0-FFE9-4316-810C-26632B9BE820Q57130288-6D7C0D3C-68D0-415D-B8F7-78B367726874Q58077688-002F8616-BC70-4825-96D8-6A24212A7B6D
P2860
Epidemiology and clinical classification of onychomycosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Epidemiology and clinical classification of onychomycosis.
@ast
Epidemiology and clinical classification of onychomycosis.
@en
type
label
Epidemiology and clinical classification of onychomycosis.
@ast
Epidemiology and clinical classification of onychomycosis.
@en
prefLabel
Epidemiology and clinical classification of onychomycosis.
@ast
Epidemiology and clinical classification of onychomycosis.
@en
P2093
P2860
P1476
Epidemiology and clinical classification of onychomycosis.
@en
P2093
European Onychomycosis Observatory
M Feuilhade de Chauvin
N Di Chiacchio
P2860
P356
10.1111/J.1468-3083.2005.01281.X
P478
19 Suppl 1
P577
2005-09-01T00:00:00Z